PRA

NEUTRALEarnings

ProAssurance Corporation

2026-02-25

Price

$24.57

+0.41%

Score9.0Priority

Signals3/8 DNA2/13 Act · 2/4 Risk

SentimentNEUTRALScore: 9

Volume1.5xvs 20d avg

Analysis

PRA is executing a high-conviction breakout driven by a massive Q4 2025 earnings beat ($0.82 EPS vs. $0.22 est) and confirmed progress on its merger with The Doctors Company. The 'ALPHA_MALE' and 'PERFECT_STACK' signals indicate institutional absorption of this structural catalyst, where the market is aggressively repricing the asset's standalone value and deal certainty despite lagging analyst skepticism. In the current RISK_ON regime, capital is rotating into this idiosyncratic, event-driven story, treating the earnings surprise as a de-risking event for the pending June 2026 merger closing.

Fired Signals

ALPHA MALEGOLDEN CROSSPERFECT STACKQUIET ACCUMULATIONMOMENTUM SHIFTWEAK FINISHCHURNING

Key Takeaways

**Structural Catalyst:** Q4 Earnings smashed consensus (4x beat), validating underwriting turnaround and merger synergies.
**Deal Certainty:** The pending acquisition by The Doctors Company (exp. closing June 30, 2026) provides a valuation floor, while the earnings beat closes the discount.
**Technical Breakout:** Price hitting new 52-week highs ($24.69) with 1.5x volume confirms the transition from 'Quiet Accumulation' to active Price Discovery.

← Back to 2026-02-25 View Full PRA History →Yahoo Finance &nearr;